Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment.
Bao S, Darvishi M, H Amin A, Al-Haideri MT, Patra I, Kashikova K, Ahmad I, Alsaikhan F, Al-Qaim ZH, Al-Gazally ME, Kiasari BA, Tavakoli-Far B, Sidikov AA, Mustafa YF, Akhavan-Sigari R. Bao S, et al. J Cancer Res Clin Oncol. 2023 Aug;149(10):7945-7968. doi: 10.1007/s00432-022-04444-w. Epub 2023 Mar 11. J Cancer Res Clin Oncol. 2023. PMID: 36905421 Review.
Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment.
Ghasemi Darestani N, Gilmanova AI, Al-Gazally ME, Zekiy AO, Ansari MJ, Zabibah RS, Jawad MA, Al-Shalah SAJ, Rizaev JA, Alnassar YS, Mohammed NM, Mustafa YF, Darvishi M, Akhavan-Sigari R. Ghasemi Darestani N, et al. Cell Commun Signal. 2023 Feb 24;21(1):43. doi: 10.1186/s12964-022-01012-0. Cell Commun Signal. 2023. PMID: 36829187 Free PMC article. Review.
The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: A systematic review of clinical evidence.
Al-Haideri MT, Mannani R, Kaboli R, Gharebakhshi F, Darvishzadehdeldari S, Tahmasebi S, Faramarzi F, Cotrina-Aliaga JC, Khorasani S, Alimohammadi M, Darvishi M, Akhavan-Sigari R. Al-Haideri MT, et al. Transpl Immunol. 2023 Aug;79:101858. doi: 10.1016/j.trim.2023.101858. Epub 2023 May 24. Transpl Immunol. 2023. PMID: 37236514 Free PMC article. Review.
Immunogenicity of COVID-19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta-analysis.
Al-Haideri M, Mohammad TAM, Darvishzadehdeldari S, Karbasi Z, Alimohammadi M, Faramarzi F, Khorasani S, Rasouli A, Tahmasebi S, Darvishi M, Akhavan-Sigari R. Al-Haideri M, et al. Int J Rheum Dis. 2023 Jul;26(7):1227-1234. doi: 10.1111/1756-185X.14713. Epub 2023 Jun 12. Int J Rheum Dis. 2023. PMID: 37309305 Review.
Role of microRNA-146a in cancer development by regulating apoptosis.
Kookli K, Soleimani KT, Amr EF, Ehymayed HM, Zabibah RS, Daminova SB, Saadh MJ, Alsaikhan F, Adil M, Ali MS, Mohtashami S, Akhavan-Sigari R. Kookli K, et al. Among authors: akhavan sigari r. Pathol Res Pract. 2024 Feb;254:155050. doi: 10.1016/j.prp.2023.155050. Epub 2023 Dec 26. Pathol Res Pract. 2024. PMID: 38199132 Review.
Recent advances in non-small cell lung cancer targeted therapy; an update review.
Araghi M, Mannani R, Heidarnejad Maleki A, Hamidi A, Rostami S, Safa SH, Faramarzi F, Khorasani S, Alimohammadi M, Tahmasebi S, Akhavan-Sigari R. Araghi M, et al. Cancer Cell Int. 2023 Aug 11;23(1):162. doi: 10.1186/s12935-023-02990-y. Cancer Cell Int. 2023. PMID: 37568193 Free PMC article. Review.
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.
Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Jayasankar N, Rao DP, Thamaraikani T, Vasanthan M, Viktor P, Lakshmaiya N, Saadh MJ, Amajd A, Abo-Zaid MA, Castillo-Acobo RY, Ismail AH, Amin AH, Akhavan-Sigari R. Chehelgerdi M, et al. Mol Cancer. 2023 Oct 9;22(1):169. doi: 10.1186/s12943-023-01865-0. Mol Cancer. 2023. PMID: 37814270 Free PMC article. Review.
69 results